TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
JSPR

Jasper Therapeutics Inc

Healthcare · Biotechnology

0.5652$ -5.5% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow JSPR
Line item 2019 2020 2021 2022 2023 2024 2025
– – – – – – –
– -94.4% +1,695.2% +247.5% -15.4% +23.9% -23.1%
– +20,066.7% -13.4% +290.4% +27.4% +27.0% +1.4%
– +440.4% -90.7% -1,712.0% – – –
– -6.9% -201.6% – – -96.6% -2,945.7%
– +0.0% +0.0% -76.3% -53.6% +106.7% -98.7%
– – -1,324.1% -76.3% -53.6% +99.3% –
– – – -99.5% -3,528.6% – -32.5%
– – – – – – –
– -61.3% +794.6% -99.9% +183,483.6% -52.6% -28.6%
– -125.7% – -171.6% – -131.4% –
– – – – – – –

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?